Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0423716 (
Neuropathic pain
)
1,417
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Activation of cutaneous C-fibers by capsaicin or sciatic nerve transection increases the number of astrocytic gap junctions as well as the levels of connexin 43 in the dorsal horn on the stimulated side. Changes in
connexin 37
mRNA expression following nerve injury have not been previously documented. We examined the role of gap junction protein
connexin 37
in neuropathic hypersensitivity following peripheral nerve injury. Study results showed ipsilaterally increased
connexin 37
mRNA levels proximally and distally in rat sciatic nerves after injury and behavioral thermal hyperalgesia at 7 and 14 days. Proximal and distal
connexin 37
mRNA levels returned to baseline by 21 days. Sciatic nerve
connexin 37
mRNA increases were proportional to the extent of thermal hyperalgesia, but skin, muscle, and lumbar spinal cord
connexin 37
mRNA showed no significant changes.
Neuropathic pain
relief correlated with downregulation of
connexin 37
mRNA. Results indicate that upregulation of
connexin 37
mRNA following sciatic nerve injury correlates with subsequent thermal hyperalgesia, which suggests that gap junctions (connexin 37) are responsible for the hyperexcitability following peripheral nerve injury.
...
PMID:Induction of connexin 37 expression in a rat model of neuropathic pain. 1197 4